Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices
Open Access
- 9 July 2002
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 9 (15), 1049-1053
- https://doi.org/10.1038/sj.gt.3301725
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapyCancer Immunology, Immunotherapy, 2001
- Heterogeneity of Angiogenic Activity in a Human Liposarcoma: a Proposed Mechanism for "No Take" of Human Tumors in MiceJNCI Journal of the National Cancer Institute, 2001
- Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicryProceedings of the National Academy of Sciences, 2001
- Angiogenesis in cancer and other diseasesNature, 2000
- Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic MimicryThe American Journal of Pathology, 1999
- Gene therapy strategies for tumor antiangiogenesisJNCI Journal of the National Cancer Institute, 1998
- Antiangiogenic therapy of experimental cancer does not induce acquired drug resistanceNature, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitroCell, 1989
- Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures.The Journal of cell biology, 1988